microRNA (miRNA)-mediated transformation of cancer cell transcriptomes underlies pathogenic mechanisms and potential therapeutic approaches. Using miRNAs for cancer therapeutics, however, has encountered roadblocks in terms of delivery efficacy, toxicity, and immunogenicity. In this webinar brought to you by The Scientist, Andrea Kasinski and Masako Harada will explore new ways to overcome these challenges and discuss how they develop more effective miRNA delivery strategies.
Topics to be covered
Ligand-based miRNA delivery
Using extracellular vesicles for targeted microRNA delivery
Tuesday, February 8, 2022
2:30 - 4:00 PM Eastern Time
Meet the speakers
Andrea Kacinski, PhD Associate Professor Biological Sciences Purdue University
Masako Harada, PhD Assistant Professor
Biomedical Engineering Michigan State University
TS_Webinar_Bio-Rad_LabTools_Droplet Digital PCR: When qPCR Doesn’t Make the Cut November 4, 2021_IO#403220
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
The Scientist c/o LabX Media Group 1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll Free: 888.788.0328 | Phone: 705.528.6888 Email: email@example.com